SKIN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Beauty Health Co (SKIN) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are bearish, the financial performance shows declining revenue and net income, and there are no significant positive catalysts in the short term. While hedge funds are buying, the overall sentiment and fundamentals do not support a confident buy decision.
The technical indicators are bearish. The MACD is below 0 and contracting negatively, RSI is neutral at 41.068, and the moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 0.979, with key support at 0.892 and resistance at 1.066.
Hedge funds are significantly increasing their buying activity, with an 87233.33% increase in the last quarter. Gross margin improved by 25.22% YoY in Q3 2025.
Analysts maintain a Hold rating with only a slight price target increase. Technical indicators are bearish, and there are no recent congress trading data or influential figure activity.
In Q3 2025, revenue dropped to $70.66M (-10.34% YoY), net income fell to -$11.03M (-39.69% YoY), and EPS declined to -$0.09 (-40% YoY). However, gross margin improved to 64.59% (+25.22% YoY).
Analyst Oliver Chen from TD Cowen raised the price target from $1.50 to $1.65 but maintained a Hold rating. The firm sees potential in the beauty sector but highlights other companies like Estee Lauder as having stronger upside potential.
